Blood count-derived immunosenescence biomarkers
5 findings
Effects
1Postoperative atrial fibrillation
no changein humans1
1 study
Postoperative atrial fibrillation
no changein humans1
Blood count-derived immunosenescence biomarkers have no effect on postoperative atrial fibrillation in humans (P = .357).
Humansisolated CABGn = 9,046
Immunosenescence biomarkers and outcomes in isolated coronary artery bypass grafting
JTCVS open9 Mar 2026
Associations
4Major adverse cardiovascular and cerebrovascular events
upin humans1
1 study
Major adverse cardiovascular and cerebrovascular events
upin humans1
Blood count-derived immunosenescence biomarkers are associated with major adverse cardiovascular and cerebrovascular events in humans (P < .001 for all).
Humansisolated CABGOver 14 years of follow-upn = 9,046
Immunosenescence biomarkers and outcomes in isolated coronary artery bypass grafting
JTCVS open9 Mar 2026
Mortality
upin humans1
1 study
Mortality
upin humans1
Blood count-derived immunosenescence biomarkers are associated with mortality in humans (P < .001 for all).
Humansisolated CABGOver 14 years of follow-upn = 9,046
Immunosenescence biomarkers and outcomes in isolated coronary artery bypass grafting
JTCVS open9 Mar 2026
Perioperative complications
upin humans1
1 study
Perioperative complications
upin humans1
Blood count-derived immunosenescence biomarkers predict perioperative complications in humans (P < .001).
Humansisolated CABGn = 9,046
Immunosenescence biomarkers and outcomes in isolated coronary artery bypass grafting
JTCVS open9 Mar 2026
Perioperative mortality
upin humans1
1 study
Perioperative mortality
upin humans1
Blood count-derived immunosenescence biomarkers predict perioperative mortality in humans (AUC 0.534-0.656, P < .001).
Humansisolated CABGn = 9,046
Immunosenescence biomarkers and outcomes in isolated coronary artery bypass grafting
JTCVS open9 Mar 2026